inhibition of resistant triple-negative breast cancer cells | oncotarget
Published 1 year ago • 484 plays • Length 9:23Download video MP4
Download video MP3
Similar videos
-
0:41
oncotarget: combination therapeutics inhibit breast cancer resistance
-
1:13
crosstalk between triple negative breast cancer and microenvironment | oncotarget
-
0:46
oncotarget: sacituzumab govitecan in triple-negative breast cancer
-
0:59
oncotarget: crispr used in triple negative breast cancer research
-
1:40
continuous abemaciclib treatment leads to breast cancer inhibition | oncotarget
-
1:00
oncotarget | notch1 variants in triple-negative breast cancer
-
1:21
endocrine resistance-causing genes in breast cancer | oncotarget
-
7:24
oncotarget: researchers identify potential therapeutic target in aggressive breast cancer cells
-
0:52
oncotarget: onc201, trail, and breast cancer
-
29:39
oncotarget: breast cancer cells to onc201 from anti-proliferative to apoptotic
-
1:49
acsl4: biomarker, mediator and target in quadruple negative breast cancer | oncotarget
-
2:15
oncotarget: table of contents - volume 12, issue 7
-
0:53
oncotarget: phenotypic changes in her2 breast cancer
-
12:54
oncotarget: onc201 kills breast cancer cells in vitro by targeting mitochondria
-
2:02
faah inhibition ameliorates breast cancer in murine model | oncotarget
-
0:57
oncotarget: clinical trial of p10s-padre vaccine in breast cancer
-
11:05
oncotarget: metabolic reprogramming of glioblastoma cells sensitizes for apoptosis
-
7:54
oncotarget: transcription and proliferation of human tumor cells
-
1:52
therapeutic potentials and challenges of cytostatic persister cancer cells | oncotarget